Delivery Order SPE2DB20D7059-SPE2DB24FPYV2
- Not listed
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a delivery order contract worth $4,326.75 by the Defense Logistics Agency Troop Support Medical to provide FLUTICASONE PROP HFA 220 MCG 12GM pharmaceutical supplies. This contract has a completion date of February 12, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with the Defense Logistics Agency valued at up to $999,999,999.00...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide $1,543.29 worth of the pharmaceutical product FLUTICASONE PROP HFA 110 MCG 12GM. The delivery order has a completion date of January 10, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division, is a prime contractor that regularly supplies pharmaceuticals, medical supplies, and distribution services to DLA...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order contract worth $1,442.25 by the Defense Logistics Agency (DLA) to provide FLUTICASONE PROP HFA 220 MCG 12GM pharmaceuticals. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, which has a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC serves...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order contract valued at $3,314.56 by the Defense Logistics Agency (DLA) to provide FLUTICASONE PROP HFA 110 MCG 12GM pharmaceutical products. The contract has a completion date of January 26, 2024. This delivery order is issued under an indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance...
- The Defense Logistics Agency (DLA) has awarded a firm fixed-price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division, worth $8,128.61, for the supply of FLUTICASONE PROP HFA 110 MCG 12GM pharmaceuticals. The contract has an ultimate completion date of September 4, 2024. AmerisourceBergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, and this contract is a part of the company's extensive federal contracting...
- The U.S. Department of Defense's Medical Supply Chain agency awarded a $1,583.04 Firm Fixed Price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the delivery of 4,564,588,436 units of the pharmaceutical product Fluticasone Prop HFA 220 MCG 12GM by May 14, 2024. Amerisourcebergen, a major pharmaceutical distribution company, has Indefinite Delivery Contracts with both the Defense Logistics Agency (DLA) Troop Support Medical and the...
- This federal contract award was granted to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,910.96 delivery order is for the supply of FLUTICASONE PROP HFA 220 MCG 12GM, a prescription medication. The contract has an ultimate completion date of July 16, 2024 and is a Firm Fixed Price arrangement. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA valued at...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $3,458.89 firm fixed price delivery order by the Defense Logistics Agency (DLA) Troop Support Medical to supply fluticasone propionate HFA 220 MCG 12GM to military treatment facilities. This delivery order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp as the prime contractor to provide a comprehensive range of pharmaceutical products and medical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a wholly-owned subsidiary of Amerisourcebergen Corporation, as a prime contractor. The contract is a firm fixed price delivery order for the supply of Fluticasone Prop HFA 44 MCG 10.6GM, a pharmaceutical product, with a potential value of $1,850.73 and a completion date of February 21, 2024. The contract does not have a set-aside designation. Amerisourcebergen Drug...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract has a potential value of $2,444.22 and a completion date of January 30, 2024. Amerisourcebergen Drug Corp, acting as the prime contractor, will provide the Department of Defense with fluticasone propionate HFA 220 mcg 12 gm...
- SPE2DB20D7059Indefinite Delivery Contract
- SPE2DB20D7059-SPE2DB24FPYV2Delivery Order
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order contract worth $1,653.53 by the Defense Logistics Agency (DLA) to provide FLUTICASONE PROP HFA 220 MCG 12GM pharmaceuticals. The contract has a completion date of February 9, 2024. Amerisourcebergen Drug Corp is the prime contractor and has previously received numerous federal contract awards from DLA Troop Support Medical to supply pharmaceuticals, medical supplies, and related distribution services in support of military treatment programs and facilities. This delivery order is not associated with any set-aside designation. Amerisourcebergen Drug Corp also holds an indefinite delivery contract with the Department of Justice Federal Bureau of Investigation Headquarters Division to provide medical supplies and prescription medications, as well as a single award indefinite delivery contract with DLA valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary contract vehicle for the company to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 2/8/24 |